Stockscreener 앱 받기
6.51
2.68%
0.17
시간 외 거래:
6.51
전일 마감가:
$6.34
열려 있는:
$6.3
하루 거래량:
2.52M
Relative Volume:
0.81
시가총액:
$2.43B
수익:
$10.53B
순이익/손실:
$-1.23B
주가수익비율:
-2.0055
EPS:
-3.246
순현금흐름:
$949.99M
1주 성능:
+4.16%
1개월 성능:
+37.05%
6개월 성능:
+8.68%
1년 성능:
-13.32%
1일 변동 폭
$6.18
$6.525
1주일 범위
$6.05
$6.535
52주 변동 폭
$4.33
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
명칭
Bausch Health Companies Inc
전화
514-744-6792
주소
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
6.51 | 2.32B | 10.53B | -1.23B | 949.99M | -3.246 |
TAK
Takeda Pharmaceutical Co Adr
|
17.63 | 55.60B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.77 | 42.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.70 | 43.16B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.79 | 30.39B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
499.73 | 21.95B | 3.17B | 1.29B | 1.01B | 27.09 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2024-08-02 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | 개시 | Raymond James | Mkt Perform |
| 2023-09-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | 다운그레이드 | Truist | Buy → Hold |
| 2022-07-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-06-13 | 재개 | JP Morgan | Overweight |
| 2021-03-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-02-17 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-24 | 개시 | Citigroup | Buy |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-02 | 개시 | Goldman | Neutral |
| 2019-10-25 | 개시 | Cowen | Outperform |
| 2019-09-12 | 개시 | Guggenheim | Buy |
| 2019-08-15 | 업그레이드 | TD Securities | Hold → Buy |
| 2019-07-19 | 개시 | Wolfe Research | Outperform |
| 2019-06-11 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2019-01-02 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | 업그레이드 | Piper Jaffray | Underweight → Neutral |
모두보기
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Bausch Health Companies Inc.: Target Price Consensus and Analysts Recommendations | BVF | CA0717341071 - marketscreener.com
Bausch Health Stock Gains Momentum as Stronger Earnings, Raised Outlook and Debt Progress Lift Investor Optimism - kalkine.ca
Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month - AOL.com
Bausch Health Stock Faces Renewed Pressure as Investor Confidence Weakens - kalkine.ca
Bausch Health: Q2 Beat And Cheap, But Debt Overhang Remains Substantial (NYSE:BHC) - Seeking Alpha
BHC Stock Price Prediction 2025-2026 | Bausch Health Companies Inc Forecast - 24/7 Wall St.
What Is Fuelling Bausch Health (TSX:BHC) Midcap Interest? - Kalkine Media
Is Bausch Health (TSX:BHC) Finding Sustainable Pharma Momentum? - kalkinemedia.com
Bausch Health Stock Faces Renewed Pressure as -1.70% Decline Signals Cautious Investor Sentiment - kalkine.ca
Bausch Health jumps 40% post-Q2 on strong earni... - Pluang
Bausch Health Stock Climbs 1.49% as Pharmaceutical Portfolio Strength and Debt Reduction Efforts Boost Investor Confidence - kalkine.ca
Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month - The Motley Fool
Bausch Health (BHC) Q2 2026 Earnings Call Transcript - AOL.com
Bausch + Lomb Updates Board, Reaffirms 2026 Guidance - VisionMonday.com
Dimensional Fund Advisors LP Raises Position in Bausch Health Cos Inc. $BHC - MarketBeat
Bausch Health CEO joins Bausch + Lomb board of directors By Investing.com - Investing.com South Africa
Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance - BioSpace
Bausch Health CEO joins Bausch + Lomb board of directors - Investing.com
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board - PR Newswire
Bausch Health requests four new Bausch + Lomb directors with about 87% stake - Stock Titan
Bausch Health Companies Inc. (BHC) Stock Analysis: Uncovering A 7.14% Upside Potential - DirectorsTalk Interviews
Renaissance Technologies LLC Has $8.51 Million Holdings in Bausch Health Cos Inc. $BHC - MarketBeat
Bausch Health Companies Stock: 5 Straight Green Days, Up 56% - Trefis
Bausch Health Cos (NYSE:BHC) Trading Down 4.1%Here's What Happened - MarketBeat
BHC Jumps As Bausch Health Crushes Q2 And Lifts Outlook - timothysykes.com
Public Employees Retirement System of Ohio Purchases 227,466 Shares of Bausch Health Cos Inc. $BHC - MarketBeat
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), Ultragenyx Pharmaceutical (RARE) and Bausch Health Companies (BHC) - The Globe and Mail
Bausch Health Cos (NYSE:BHC) Upgraded by Wall Street Zen to "Strong-Buy" Rating - MarketBeat
Canadian Stock Movers for Friday | Bausch Health Companies Inc Was the Top Gainer; ManufacturingApparel & Accessories Led Gains - moomoo.com
Bausch Health Cos (NYSE:BHC) Trading 8.2% HigherStill a Buy? - MarketBeat
Update: Bausch Health Shares Rise After Higher Q2 Results, Raised 2026 Revenue Outlook - Moomoo
Earnings call transcript: Bausch Health tops Q2 2026 estimates, lifts guidance - Investing.com
Bausch: Q2 Earnings Snapshot - WKYC
Bausch Health Q2 Revenue Rises 13 Percent to $2.85 Billion - Quiver Quantitative
Bausch Health surges on earnings beat and raised guidance By Investing.com - Investing.com Nigeria
(Pr)ELIDEL® (pimecrolimus) cream Now Reimbursed Under Alberta's Public Drug Plan for Eligible Patients with Mild to Moderate Atopic Dermatitis - PR Newswire Canada
Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect - Yahoo! Finance Canada
Bausch Health Companies Inc. (BHC) Stock Analysis: Potential 62.95% Upside Amidst Mixed Signals - DirectorsTalk Interviews
Q2 EPS Estimate for Bausch Health Cos Decreased by Analyst - MarketBeat
Bausch Health Companies Inc expected to post earnings of $1.04 a shareEarnings Preview - TradingView
Bausch Health Companies Inc expected to post earnings of $1.01 a shareEarnings Preview - TradingView
Bausch Health (TSX:BHC) Maps Out A Fresh Pharma Roadmap - Kalkine Media
Bausch Health Companies Inc (BHC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bausch Health Companies Inc (BHC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Zacks Research Cuts Earnings Estimates for Bausch Health Cos - MarketBeat
Bausch Health Companies Inc (BHC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bausch Health Companies Inc - TradingKey
Healthcare of Ontario Pension Plan Trust Fund Sells 452,119 Shares of Bausch Health Cos Inc. $BHC - MarketBeat
BHC|Bausch Health Companies Inc|Price:4.430|Chg%:-0.015 - TradingKey
Bausch Health Companies Inc (BHC) Institutional Confidence - TradingKey
Bausch Health Cos (NYSE:BHC) Upgraded by Jefferies Financial Group to Hold Rating - MarketBeat
Bausch Health Companies Inc (BHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.79%
5.15%
자본화:
|
볼륨(24시간):